Neurohumoral variability in left ventricular dysfunction

[1]  J. Oates,et al.  Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man , 1979, Circulation.

[2]  Salim Yusuf,et al.  Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. , 1990, The American journal of cardiology.

[3]  J. Rouleau,et al.  Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. , 1989, The American journal of cardiology.

[4]  E. Platia,et al.  Pacemaker syndrome in activity-responsive VVI pacing. , 1989, The American journal of cardiology.

[5]  M. Dolgin,et al.  Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .

[6]  J. Cohn,et al.  Sequential neurohumoral measurements in patients with congestive heart failure. , 1988, American heart journal.

[7]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[8]  J. Cohn,et al.  The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.

[9]  C. Benedict,et al.  Rapid, simplified radioimmunoassay of arginine-vasopressin and atrial natriuretic peptide in plasma. , 1988, Clinical chemistry.

[10]  S. Gottlieb,et al.  Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. , 1989, Journal of the American College of Cardiology.

[11]  B. W. East,et al.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. , 1985, British heart journal.

[12]  J. Laragh,et al.  Radioimmunoassay of plasma renin activity. , 1975, Seminars in nuclear medicine.

[13]  J. Cohn,et al.  Increased plasma arginine vasopressin levels in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.

[14]  J. Laragh,et al.  Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. , 1987, The American journal of cardiology.

[15]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[16]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[17]  E. Cauter,et al.  Multifactorial control of the 24-hour secretory profiles of pituitary hormones , 1985, Journal of endocrinological investigation.

[18]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[19]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[20]  B. Pitt,et al.  Neurohumoral activation during exercise in congestive heart failure. , 1986, The American journal of medicine.

[21]  B. Pitt,et al.  Sympathetic Inhibition with Methyldopa in Heart Failure , 1986, Journal of cardiovascular pharmacology.

[22]  Y. Matsuda,et al.  Diurnal change of plasma atrial natriuretic peptide concentrations in patients with congestive heart failure. , 1989, American heart journal.

[23]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[24]  P. W. Willis,et al.  Spontaneous neurohormonal fluctuation in chronic congestive heart failure. , 1988, The American journal of cardiology.